Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe

Author:

Mereckiene J12,Cotter S21,Weber J T3,Nicoll A4,D'Ancona F51,Lopalco P L4,Johansen K4,Wasley A M6,Jorgensen P6,Lévy-Bruhl D71,Giambi C51,Stefanoff P81,Dematte L91,O’Flanagan D12,the VENICE project gatekeepers group Collective10

Affiliation:

1. Vaccine European New Integrated Collaboration Effort (VENICE) Project

2. Health Protection Surveillance Centre, Dublin, Ireland

3. Centers for Disease Control and Prevention, Atlanta, United States

4. European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden

5. National Institute of Health (Istituto Superiore di Sanità, ISS), Rome, Italy

6. World Health Organization (WHO), Office for Europe, Copenhagen, Denmark

7. French Institute for Public Health Surveillance (Institut de Veille Sanitaire, InVS), Saint-Maurice, France

8. National Institute of Public Health - National Institute of Hygiene, Warsaw, Poland

9. CINECA Consortium of University, Bologna, Italy

10. Vaccine European New Integrated Collaboration Effort (VENICE) project gatekeepers group are listed at the end of the article

Abstract

In August 2010 the Vaccine European New Integrated Collaboration Effort (VENICE) project conducted a survey to collect information on influenza A(H1N1)pdm09 vaccination policies and vaccination coverage in the European Union (EU), Norway and Iceland. Of 29 responding countries, 26 organised national pandemic influenza vaccination and one country had recommendations for vaccination but did not have a specific programme. Of the 27 countries with vaccine recommendations, all recommended it for healthcare workers and pregnant women. Twelve countries recommended vaccine for all ages. Six and three countries had recommendations for specific age groups in children and in adults, countries for specific adult age groups. Most countries recommended vaccine for those in new risk groups identified early in the pandemic such as morbid obese and people with neurologic diseases. Two thirds of countries started their vaccination campaigns within a four week period after week 40/2009. The reported vaccination coverage varied between countries from 0.4% to 59% for the entire population (22 countries); 3% to 68% for healthcare workers (13 countries); 0% to 58% for pregnant women (12 countries); 0.2% to 74% for children (12 countries). Most countries identified similar target groups for pandemic vaccine, but substantial variability in vaccination coverage was seen. The recommendations were in accordance with policy advice from the EU Health Security Committee and the World Health Organization.

Publisher

European Centre for Disease Control and Prevention (ECDC)

Subject

Virology,Public Health, Environmental and Occupational Health,Epidemiology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3